There's a particular kind of tired that shows up somewhere around forty five, and it's rude about it. Seven hours of real sleep, and you still spend the whole next day pushing uphill. This week's compound is getting more community attention than anything else for exactly that feeling.
Why people are actually taking this
SS-31, also sold as elamipretide, doesn't spread out through your whole body the way most peptides do. It heads straight for your mitochondria, the part of your cells that makes your energy, and works to keep that machinery from running down.
Community reports cluster around less of an afternoon crash, less brain fog, and faster recovery, usually somewhere in the six to twelve week range. There's also a running conversation about using it as a mitochondrial "tune-up" before other peptides, MOTS-c especially, a reasonable theory that nobody's actually tested. The one hard clinical win it has is in a rare disease most of us will never encounter. Everything else, including the stacking, is the community reading real biology forward. Worth knowing before you build a plan around it.
Since we do this for a living
Nine vendors in this space have closed since last year. If your first guess is that fewer vendors means higher prices, our own daily tracking says the opposite happened for most compounds. We pulled the actual numbers in a separate piece this month.
Want the full breakdown on SS-31 itself, reported timelines, and the stacking questions we didn't have room for here? It's all in SS-31: The Mitochondria Peptide.
Reply if there's a compound you want us to take apart like this. Until next Saturday.